Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DGX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGXQuest Diagnostics$177.09+1.6%$174.20$146.17▼$182.38$19.49B0.461.42 million shs616,268 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGXQuest Diagnostics+1.61%+3.67%+2.03%+0.07%+21.18%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDGXQuest Diagnostics4.7853 of 5 stars1.35.04.24.73.42.52.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDGXQuest Diagnostics 2.67Moderate Buy$186.005.03% UpsideCurrent Analyst Ratings BreakdownLatest DGX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/23/2025DGXQuest DiagnosticsEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$185.007/23/2025DGXQuest DiagnosticsWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform7/23/2025DGXQuest DiagnosticsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$190.00 ➝ $192.007/23/2025DGXQuest DiagnosticsDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$160.00 ➝ $178.007/18/2025DGXQuest DiagnosticsUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$176.00 ➝ $175.00(Data available from 8/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDGXQuest Diagnostics$9.87B2.01$13.73 per share12.90$64.97 per share2.73Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDGXQuest Diagnostics$871M$8.3521.2116.882.319.01%15.24%6.64%10/28/2025 (Estimated)Latest DGX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/22/2025Q2 2025DGXQuest Diagnostics$2.57$2.62+$0.05$2.47$2.73 billion$2.76 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDGXQuest Diagnostics$3.201.81%N/A38.32%14 YearsLatest DGX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/14/2025DGXQuest Diagnosticsquarterly$0.801.86%7/7/20257/7/20257/21/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDGXQuest Diagnostics0.711.090.99Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDGXQuest Diagnostics88.06%Insider OwnershipCompanyInsider OwnershipDGXQuest Diagnostics8.16%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDGXQuest Diagnostics56,000111.82 million102.70 millionOptionableDGX HeadlinesRecent News About These CompaniesMass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer TypesAugust 7 at 9:08 AM | prnewswire.comING Groep NV Acquires 2,764 Shares of Quest Diagnostics Incorporated (NYSE:DGX)August 7 at 5:57 AM | marketbeat.comBlair William & Co. IL Increases Stock Position in Quest Diagnostics Incorporated (NYSE:DGX)August 7 at 5:55 AM | marketbeat.comBank of Nova Scotia Has $2.26 Million Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX)August 7 at 4:14 AM | marketbeat.comAnalyzing Quest Diagnostics (NYSE:DGX) and Xcelerate (OTCMKTS:XCRT)August 7 at 2:57 AM | americanbankingnews.comQuest Diagnostics Incorporated (NYSE:DGX) Shares Sold by Levin Capital Strategies L.P.August 6 at 6:41 AM | marketbeat.comTIAA Trust National Association Invests $270,000 in Quest Diagnostics Incorporated (NYSE:DGX)August 6 at 4:26 AM | marketbeat.comQuest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical CareAugust 5, 2025 | prnewswire.comCetera Investment Advisers Has $3.89 Million Position in Quest Diagnostics Incorporated (NYSE:DGX)August 5, 2025 | marketbeat.com15,059 Shares in Quest Diagnostics Incorporated (NYSE:DGX) Purchased by Liberty Wealth Management LLCAugust 4, 2025 | marketbeat.comQuest Diagnostics Incorporated (NYSE:DGX) Shares Sold by J. Safra Sarasin Holding AGAugust 4, 2025 | marketbeat.comNatixis Advisors LLC Grows Position in Quest Diagnostics Incorporated (NYSE:DGX)August 4, 2025 | marketbeat.comMackenzie Financial Corp Has $2.12 Million Stake in Quest Diagnostics Incorporated (NYSE:DGX)August 4, 2025 | marketbeat.comKarthik Kuppusamy Sells 2,210 Shares of Quest Diagnostics Incorporated (NYSE:DGX) StockAugust 2, 2025 | marketbeat.comQuest Diagnostics Incorporated (NYSE:DGX) SVP Karthik Kuppusamy Sells 8,269 SharesAugust 2, 2025 | marketbeat.comQuest Diagnostics Incorporated (NYSE:DGX) SVP Sells $375,700.00 in StockAugust 2, 2025 | insidertrades.comBlueshift Asset Management LLC Purchases New Holdings in Quest Diagnostics Incorporated (NYSE:DGX)August 2, 2025 | marketbeat.comXTX Topco Ltd Makes New $1.32 Million Investment in Quest Diagnostics Incorporated (NYSE:DGX)August 2, 2025 | marketbeat.comQuest Diagnostics (NYSE:DGX) Raised to "Buy" at Wall Street ZenAugust 2, 2025 | americanbankingnews.comQuest Diagnostics (NYSE:DGX) Raised to Buy at Wall Street ZenAugust 2, 2025 | marketbeat.comTredje AP fonden Raises Stake in Quest Diagnostics Incorporated (NYSE:DGX)August 1, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDGX Company DescriptionsQuest Diagnostics NYSE:DGX$177.08 +2.82 (+1.62%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$176.97 -0.12 (-0.06%) As of 08/8/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era AppLovin’s Q2 Miss Spooks Market, But Wall Street Doubles Down DraftKings Posts Record Quarter, Eyes Profitability Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
